Nasma Boumajdi

Nasma Boumajdi

Auto-generated profile, based on publicly available information

Nasma Boumajdi

Laboratory of Biotechnology, Medical and Pharmacy School, Mohammed V University, Rabat, Morocco

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 August 2022 in The Journal of Infection in Developing Countries
Verified
Journal Article
Open access
PDF file
SMSafae El Mazouri
Safae El Mazouri
HBHouda Bendani
Houda Bendani
NBNasma Boumajdi
Nasma Boumajdi
TATarik AANNIZ
Tarik AANNIZ
IKIlham Kandoussi
Ilham Kandoussi
MOMouna Ouadghiri
Mouna Ouadghiri
Introduction: Since the COVID-19 pandemic began in December 2019, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has continuously evolved with many variants of concern emerging across the world. Methodology: In order to monitor the evolution of these variants in Morocco, we analyzed a total of 2130 genomes of the delta variant circulating around the world. We also included 164 Moroccan delta variant sequences in our analysis. Results: Our findings suggest at least four introductions from multiple international sources and a rise of a dominant delta sub-lineage AY.33 in Morocco. Moreover, we report three mutations in the N-terminal domain of the S protein specific to the Moroccan AY.33 isolates, T29A, T250I and T299I. The effect of these mutations on the secondary structure and the dynamic behavior of the S protein N-terminal domain was further determined. Conclusions: We conclude that these mutations might have functional consequences on the S protein of SARS-CoV-2.